About IQVIA Biotech
IQVIA Biotech is a company based in Durham (United States) founded in 1997. It operates as a B2B. IQVIA Biotech offers products and services including Clinical Development Solutions and Therapeutic Expertise. IQVIA Biotech operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Durham, United States
- SectorsHealthcare
- Website iqviabiotech.com
- Social LinkedIn X
- Legal Name Iqvia Biotech
Products & Services of IQVIA Biotech
IQVIA Biotech offers a comprehensive portfolio of products and services, including Clinical Development Solutions and Therapeutic Expertise.
Provides support for drug development pipelines and trials.
Offers specialized knowledge in oncology and cell therapies.
People of IQVIA Biotech
1269 people are tracked at IQVIA Biotech (701 in leadership, 9 in board & advisors, 559 in team).
| Name | Role | Group |
|---|---|---|
Peter Scilipote | Vice President, Business Transformation | Leadership |
Lynda Curtin | Director Clinical Operations -site Management | Leadership |
Oana Borse | Director, Strategic Sourcing R&ds | Leadership |
David Peig | Senior Director - Rare Disease BU & GTM Strategy | Leadership |
Mike Davis | Sr. Director, Strategic Business Development (r&d Solutions) | Leadership |
Ryan Deterding | Vice President And Global Account Director | Leadership |
Iqbal Thaker | Assoc. Director - IT Projects | Leadership |
Jennifer Millard | Vice President | Leadership |
Arthur Jenkins | Senior Director, Porfolio Project Management And Development Engineering | Leadership |
Manoj Singh | Director Of Software Engineering | Leadership |
Ester Pavon | Associate Director, Clinical Project Management | Leadership |
Nuno Dias | Senior Director, IT (head Of Technology) | Leadership |
Alexey Levashov | Associate Clinical Project Management Director | Leadership |
Chris Nickum | Vice President And General Manager, Commercial Solutions And Insights Hub (csih) | Leadership |
Fumihiko Ugajin | President - Japan | Leadership |
Stormie R. Crouch | Senior Director, Business Development | Leadership |
Avery Pasch | Account Director | Leadership |
Abbygail Boswell | International Project Associate Director | Leadership |
Susan Grant Schneider | Senior Vice President | Leadership |
Melissa Daily | Associate Director, Human Resources | Leadership |
1249 more people are available in the full profile.
Complete people profiles for IQVIA Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of IQVIA Biotech
IQVIA Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novartis.com | 1996 | Basel, Switzerland | – | 97 | R&D focused on manufacturing of drugs for multiple therapeutic areas | |
| catalent.com | 2007 | Somerset, United States | – | 9,390 | CDMO offering drug and biologics development services | |
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| biotage.com | 2009 | Uppsala, Sweden | – | – | Organic synthesis, analytical, and peptide chemistry services for drug discovery and development | |
| curiaglobal.com | 1991 | Albany, United States | – | 1,918 | Drug research, development, testing, and consulting services are provided. | |
| amplify-bio.com | 2021 | Hilliard, United States | $229.75M | – | Provides contract research, development, and manufacturing services for biologic drugs. | |
| wuxibiologics.com | 2008 | Shanghai, China | – | 257 | Protein therapeutics are developed and manufactured by WuXi Biologics. | |
| tirupatigroup.co.in | 1980 | Paonta Sahib, India | $51.55M | 1,827 | Pharmaceutical products are manufactured under contract by Tirupati Medicare. | |
| indapta.com | 2016 | Seattle, United States | $72.5M | – | Limited information available |
Detailed competitors of IQVIA Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IQVIA Biotech
Websites that share an audience with IQVIA Biotech (iqviabiotech.com).
Websites whose visitors overlap most with IQVIA Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| opella.com | 90% | 78.4K | #531,814 | View details | |
| allucent.com | 82% | 34.5K | #991,439 | View details | |
| medreps.com | 56% | 47.7K | #546,705 | View details |
Latest news on Iqvia Biotech
Complete news archive for IQVIA Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to IQVIA Biotech
10 companies that operate in the same segment as IQVIA Biotech (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IQVIA Biotech
IQVIA Biotech was founded in 1997.
IQVIA Biotech is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
IQVIA Biotech is a full-service contract research organization focused on clinical development for biotech innovators. They deliver specialized services in areas like oncology, cell and gene therapy, and internal medicine, helping navigate drug pipelines from innovation to patient impact. With global teams, they provide strategic support and therapeutic expertise to ensure successful trials and milestones for clients in various therapeutic fields.
IQVIA Biotech offers Clinical Development Solutions and Therapeutic Expertise.
IQVIA Biotech operates through Iqvia Biotech.